Discover
JAZZ
Jazz Pharmaceuticals plc
247.98
1 x 247.99
1 x 252.82
bid
ask
-
8.54
3.33%
100 @ 04:00 PM
248.05 +0.07 (0.03%)
| Ytd | 45.87% | |
| 1y | 123.91% |
246.48
day range
257.16
110.26
52 week range
265.05
| Open | 256.75 | Prev Close | 256.52 | Low | 246.48 | High | 257.16 | Mkt Cap | 15.58B |
| Vol | 1.01M | Avg Vol | 864.22K | EPS | 26.82 | P/E | 9.25 | Forward P/E | 9.94 |
| Beta | 0.36 | Short Ratio | 4.42 | Inst. Own | 105.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 241.78 | 200-d Avg | 195.02 | 1yr Est | 280.95 |
| Income Statement | |||
| Total Revenue | 1.21B | ||
| Revenues (USD) | 1.21B | ||
| Cost of Revenue | 116.40M | ||
| Gross Profit | 1.09B | ||
| Operating Expenses | 843.70M | ||
| Research and Development Expense | 207.50M | ||
| Selling, General and Administrative Expense | 389.20M | ||
| Operating Income | 248.20M | ||
| Interest Expense | 37.10M | ||
| Income Tax Expense | 18.10M | ||
| Net Income | 192.80M | ||
| Net Income Common Stock | 192.80M | ||
| Net Income Common Stock (USD) | 192.80M | ||
| Consolidated Income | 192.80M | ||
| Earnings per Basic Share | 3.05 | ||
| Earnings per Basic Share (USD) | 3.05 | ||
| Earnings per Diluted Share | 2.78 | ||
| Earning Before Interest & Taxes (EBIT) | 248.00M | ||
| Earning Before Interest & Taxes (USD) | 248.00M | ||
| Weighted Average Shares | 63.20M | ||
| Weighted Average Shares Diluted | 69.40M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.62B | ||
| Cash and Equivalents (USD) | 1.62B | ||
| Investments | 580.00M | ||
| Investments Current | 580.00M | ||
| Trade and Non-Trade Receivables | 880.90M | ||
| Current Assets | 3.97B | ||
| Property, Plant & Equipment Net | 264.10M | ||
| Total Assets | 11.08B | ||
| Debt Current | 1.02B | ||
| Total Debt | 4.39B | ||
| Current Liabilities | 2.23B | ||
| Debt Non-Current | 3.38B | ||
| Total Liabilities | 6.28B | ||
| Accumulated Retained Earnings (Deficit) | 1.13B | ||
| Accumulated Other Comprehensive Income | -662.50M | ||
| Shareholders Equity | 4.80B | ||
| Shareholders Equity (USD) | 4.80B | ||
| Assets Non-Current | 7.11B | ||
| Total Debt (USD) | 4.39B | ||
| Goodwill and Intangible Assets | 5.83B | ||
| Inventory | 443.00M | ||
| Liabilities Non-Current | 4.05B | ||
| Trade and Non-Trade Payables | 128.50M | ||
| Tax Assets | 926.40M | ||
| Tax Liabilities | 584.80M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 179.10M | ||
| Net Cash Flow from Financing | -994.50M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -224.50M | ||
| Capital Expenditure | -18.10M | ||
| Issuance (Purchase) of Equity Shares | -9.50M | ||
| Issuance (Repayment) of Debt Securities | -1.01B | ||
| Net Cash Flow from Investing | 354.90M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 450.00M | ||
| Net Cash Flow from Operations | 415.70M | ||
| Effect of Exchange Rate Changes on Cash | -600.00K | ||
| Share Based Compensation | 73.30M | ||